Molecular cellular mechanisms of therapeutic action of probiotic drugs


如何引用文章

全文:

详细

The data for molecular-cellular mechanisms of immunomodulatory effects of probiotics are presented. The fundamentally actions of these drugs are ability of interact surface structures and DNA of these symbiotic bacteria with Toll-like receptors. Important role play living bacterial cells of probiotic strains as well as their metabolites and antigenic complexes, because they mediate signaling pathways after ligand-retseptor contact with the dendrites, epithelial cells, and many other immunocompetent cells of innate immunity. Probiotics' properties of the drug in addition to immunomodulating activity of the introduced species are largely dependent on the used strain of probiotic. However, only clinical data allow us to select the optimal therapeutic and preventive probiotic.

作者简介

V Bondarenko

V Bondarenko

参考

  1. Бондаренко В.М. Поликомпонентные пробиотики: механизм действия и терапевтический эффект при дисбиозах кишечника // Фарматека. 2005. № 115. С.46-54.
  2. Isolauri E, Kirjavainen PV, Salminen S. Probiotics: role in the treatment of intestinal infection and inflammation. Gut. 2002;50(Suppl 3):154-59.
  3. Tennyson CA, Friedman G. Microecology, obesity and probiotics. Curr.Opin.Endocrinol.Diabetes Obes. 2008;15(5):422-27.
  4. Kaur IP, Kuhad A, Garg A, et al. Probiotics: delineation of prophylactic and therapeutic benefits. J.Med.Food. 2009;12(2):219-35.
  5. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotic, probiotics, and prebiotics: gastroenterology enters the metagenomic era. Gastroenterology. 2009;136:2015-31.
  6. Бондаренко В.М., Лиходед В.Г. Взаимодействие кишечной микрофлоры с Toll-подобными рецепторами // Иммунология. 2009. № 5. С. 317-20.
  7. Rhee, KJ, Sethupathi P, Driks A. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 2004;172(2):1118-24.
  8. Pickard KM, Bremner AN, Gordon JN, et al. Microbial-gut interactions in health and disease. Immune responses. Вest Pract. Res. Clin. Gastrоenterol. 2004;18(2):271-85.
  9. Бондаренко В.М., Мацулевич Т.В. Дисбактериоз кишечника как клинико-лабораторный синдром: современное состояние проблемы. ГЭОТАР. М., 2007.
  10. Blandino G, Fazio D, Marco R. Probiotics: overview of microbiological and immunological characteristics. Expert Rev.Anti Infect.Ther. 2008;6(4):497-508.
  11. Долгушин И.И., Андреева Ю.С. Нейтрофильные внеклеточные ловушки: метод обнаружения и оценка эффективности улавливания бактерий// Журн. микробиол. 2009. № 2. C. 70-73.
  12. Ковальчук Л.В., Хорева Р.В., Варивода А.С. Врожденные компоненты иммунитета: Toll-подобные рецепторы в норме и иммунопатологии// Журн.микробиол. 2005. №4. C. 96-104.
  13. Хаитов Р.М., Пащенков М.В., Пинегин Б.В. Роль паттернраспознающих рецепторов во врожденном и адаптивном иммунитете// Иммунология. 2009. № 1. C.66-76.
  14. Armant MA, Matthew EJ. Toll-like receptors: a family pattern-recognition receptors in mammals. Genome Biol. 2002;3(1):3011-20.
  15. Underhill DM, Ozinscy A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 2002;14:103-10.
  16. Маянский А.Н. Маянский Н.А., Заславская М.И. Нуклеарный фактор kB и воспаление// Цитокины и воспаление. 2007. Том 6. № 2.С.3-9.
  17. Tak PP, Firestein GS. NF-kB: a key role in inflammatory diseases. J. Clin. Invest. 2001;107(1):7-11.
  18. Karlsson H, Larsson P, Wold AE, et al. Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differenciate into dendritic cells. Infect. Immun. 2004;72(5):2671-78.
  19. Abrea MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J.Immunol. 2005; 174(8): 4453-4460.
  20. Rakoff-Nahoum S, Paglino J, Esmali-Varzaeh F, et al. Recognition of commensal microflora by toll-like receptors for intestinal homeostasis. Cell. 2004;118(2):229-41.
  21. Uhlig HH. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity. 2006;25:309-18.
  22. Perdigon G, Galdeano CM, Valdez JC, et al. Interaction of lactic acid bacteria with gut immune system. Eur. J. Clin. Nutr. 2002;56:21-26.
  23. Galdeano CM, Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 2006;13(2):219-26.
  24. Vinderola G, Matar C, Perdigon G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin. Diagn. Lab. Immunol. 2005;12(9):1075-84.
  25. Chapman TM, Plosker GL,Figgitt DP. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs. 2006;66(10):1371-87.
  26. Rachmilevitz D, Katakura K, Karmeli F. et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effect of probiotics murine experimental colitis. Gastroenterol. 2004;126(2):520-28.
  27. Sun J, Shi JH, Le GW, et al. Distinct immune response induced by peptidoglycan derived from Lactobacillus spp. World J. Gastroenterol. 2005;11 (40):6330-37.
  28. Hoarau C., Lagaraine C., Martin L. et al. Supernatant of Bifidobacterium breve induced dendritic cell maturation, activation and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immunol. 2006;117(3):696-702.
  29. Mastrandrea F, Coradduzza G, Serio G, et al. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Allerg. Immunol. (Paris).2004;36(4):118-22.
  30. Kitazawa H, Watanabe H, Shimosato T, et al. Immunostimulatory oligonucleotide, CpG-like motif exists in Lactobacillus delbrueckii ssp bulgaricus NIAI B6. Int. J. Food Microbiol. 2003;85(1-2):11-21.
  31. Shimosato T, Kimura T, Tohno M, et al. Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'- C…G-3'stem structure. Cell Microbiol. 2006;8(3):485-95.
  32. Sudo N, Aiba Y, Oyama N, et al. Dietary nucleic acid and intestinal microbiota synergistically promote a shift in the Th1/Th2 balance towards Th1-skewed immunity. Int.Arch.Allergy Immunol. 2004;135(2):132-35.
  33. Takahashi N, Kitazawa H, Shimosato T, et al. An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro. FEMS Immunol.Med. Microbiol. 2006;46(3):461-69.
  34. Vidal K, Donnet-Hughes A, Granato D. Lipoteichoic acid from Lactobacillus johsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect. Immun. 2002;70( 4):2057-64.
  35. Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implication for fundamental and biomedical research. Appl. Envir. Microbiol. 2008;74(16):4985-96.
  36. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2501&mid=1085056570&magid=186

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2010
##common.cookie##